By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


ContraFect Corporation 

28 Wells Avenue, Third Floor

Yonkers  New York   10701  U.S.A.
Phone: 914-207-2300 Fax: n/a



Company News
ContraFect (CFRXU) Announces Issuance Of Key Patent Covering Novel Lysin Technology 7/20/2015 7:57:30 AM
ContraFect (CFRXU) Announces $20,000,000 Private Placement 6/12/2015 12:30:22 PM
ContraFect (CFRXU) Announces First Healthy Volunteer Dosed With CF-301 5/21/2015 10:01:50 AM
ContraFect (CFRXU) Adds Former Cubist Executive Steven C. Gilman, PhD, To Board Of Directors As Executive Chairman 5/20/2015 10:15:55 AM
ContraFect (CFRXU) Announces First Quarter 2015 Results 5/15/2015 10:47:46 AM
ContraFect (CFRXU) Announces Commencement Of Phase 1 Clinical Trial Of Cf-301 For Staph Bloodstream Infections, Including MRSA 4/29/2015 10:55:04 AM
ContraFect (CFRXU) Announces Fourth Quarter And Full Year 2014 Results 4/6/2015 10:27:07 AM
ContraFect (CFRXU) To Present At 27th Annual ROTH Conference 3/3/2015 9:59:48 AM
BIOCEO15: ContraFect (CFRXU) CEO Says Lysin, AB Anti-Infectives Are “Game-Changers” in 2015 2/9/2015 2:25:16 PM
ContraFect Corporation (CFRXU) To Present at 17th Annual BIO CEO & Investor Conference 2/5/2015 12:39:04 PM